FAA Investigates JFK Near Miss as Congress, Obesity Drug Coverage Draw Scrutiny
The FAA is investigating a second recent near-miss incident at a major U.S. airport after an American Airlines regional jet came close to an Air Canada jet at JFK following an aborted landing. Separately, approximately 12 million Americans lost insurance coverage for each of the obesity drugs Zepbound and Wegovy over the past year, according to GoodRx data. Other news includes congressional dysfunction, a UN reparations vote, criticism of Trump's Iran ceasefire handling, and the launch of a children's podcast by Second Lady Usha Vance.
Progressive outlets emphasize the systemic failure to provide equitable access to obesity medications, highlight the UN reparations vote as a meaningful step toward addressing historical injustices, and frame congressional gridlock as a product of Republican legislative dysfunction.
The factual record shows two confirmed near-miss aviation incidents at major U.S. airports under active FAA investigation, a documented loss of obesity drug coverage for roughly 24 million total patients across two medications, a UN vote recognizing the transatlantic slave trade as a crime against humanity, and ongoing criticism of executive branch foreign policy from across the political spectrum.
Conservative outlets flag criticism from within right-leaning circles — such as Byron York's assessment that Trump moved too eagerly in Iran ceasefire talks — while noting Usha Vance's podcast as a positive cultural initiative and raising concerns about federal aviation oversight failures.
The factual record shows two confirmed near-miss aviation incidents at major U.S. airports under active FAA investigation, a documented loss of obesity drug coverage for roughly 24 million total patients across two medications, a UN vote recognizing the transatlantic slave trade as a crime against humanity, and ongoing criticism of executive branch foreign policy from across the political spectrum.
The FAA is investigating at least two recent near-miss incidents at major U.S. airports, while 12 million patients each lost coverage for Zepbound and Wegovy over the past year.